| Literature DB >> 32287310 |
.
Abstract
Entities:
Year: 2020 PMID: 32287310 PMCID: PMC7156085 DOI: 10.1371/journal.pone.0231923
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 2Cytotoxicity of the TMTP1-DKK peptide in various cell lines.
A, B, C Cell survival rates were determined by MTT assays performed in triplicate (error bars, ±SD). The data presented represent the percentage of cells surviving compared to untreated cells. Representative results are shown. The differences of survival rates between 10 μM and 20 μM TMTP1-DKK are more significant in either PC-3M-1E8 or MKN-45sci cells (P<0.01). However, little or no effect was seen on murine fibroblast NIH/3T3 cell proliferation when they were treated with TMTP1-DKK. D Cells viability of MKN-45 and PC-3M-1E8 cancer cells treated different concentrations (0–20 μM) of svTMTP1-DKK for 24 hour was measured by MTT assay. E Morphological quantification of cellular apoptosis by inverted microscope in PC-3M-1E8 and MKN-45sci cells treated with 10 μM TMTP1-DKK. After treated with DKK, the cells showed cell shrinkage, membrane disintegration, and nuclear condensation/fragmentation. F Little Morphological change was observed by inverted microscope in PC-3M-1E8 and MKN-45sci treated with 10 μM svTMTP1-DKK for 24 hour.
Fig 4TMTP1-DKK inhibits cell migration.
A Cells were incubated with 2 μM TMTP1-DKK peptide for 12 h. Transwell migration assays of PC-3M-1E8 cells and MKN-45sci cells were performed. After 24 h incubation, cells from the upper side of the filter were removed and cells from the lower surface of the filter were fixed and stained. Data are the means ± SE of three independent experiments; each performed in triplicate. B Cellular migration was reduced by 52.38±3.3% in PC-3M-1E8 cells and 46.16±2.7% in MKN-45sci cells compared to the appropriate controls.